...
首页> 外文期刊>Annals of Plastic Surgery >Indications for extra full projection anatomical cohesive silicone gel implants in cosmetic and reconstructive breast surgery.
【24h】

Indications for extra full projection anatomical cohesive silicone gel implants in cosmetic and reconstructive breast surgery.

机译:适用于整形和重建性乳房手术的额外全投影解剖学粘结硅胶凝胶植入物的适应症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In 2003, a new extra full projection (EFP) anatomic cohesive silicone gel breast implant was introduced onto the European market. This review presents the early experience of a single surgeon with this new implant over a 29-month period. Between 2003 and 2006, the McGhan Style 410 EFP breast implants were inserted for highly selected indications. Twenty-eight patients received a total of 47 EFP implants. Their age range was 23 to 66 years (mean: 46 years). The implant was used in 6 primary and 7 revisional cosmetic breast augmentation patients. The series included 9 postmastectomy breast reconstructions. In further, 6 patients the implant was used to revise existing breast reconstructions. After a mean follow-up period of 31 months, there were no infections, malrotations, or significant capsular contractures and no patients have required revisional implant surgery. The novel implant was successfully used to address specific challenges in cosmetic and reconstructive breast surgery. These included large skin envelopes in breast augmentation patients declining mastopexy, complicated implant exchanges, and suboptimal prosthetic breast reconstructions. This prosthesis may prove a useful addition to the range of breast implants available, especially when there is an overlap of challenging esthetic problems.
机译:2003年,一种新的超全投影(EFP)解剖型粘性硅胶凝胶乳房植入物被引入了欧洲市场。这篇综述介绍了单个外科医生在29个月的时间内使用这种新植入物的早期经验。在2003年至2006年之间,为高度选择适应症而插入了McGhan Style 410 EFP乳房植入物。 28位患者总共接受了47枚EFP植入物。他们的年龄范围是23至66岁(平均46岁)。该植入物用于6例原发性和7例修订性美容性隆胸患者。该系列包括9例乳房切除术后乳房再造。另外,有6位患者使用植入物修改了现有的乳房再造。平均随访31个月后,没有感染,旋转异常或明显的囊膜挛缩,也没有患者需要进行翻修植入物手术。新型植入物已成功用于解决整容和重建乳房手术中的特定挑战。这些包括隆胸患者中的大皮肤包膜,导致马托吡昔片减少,复杂的植入物更换以及假体修复效果欠佳。这种假体可能被证明是可用的乳房植入物的有益补充,特别是当挑战性美学问题重叠时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号